Sandra Schulz
Overview
Explore the profile of Sandra Schulz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Panitz V, Koncarevic S, Sadik A, Friedel D, Bausbacher T, Trump S, et al.
Theranostics
. 2021 Oct;
11(19):9217-9233.
PMID: 34646367
Tryptophan (Trp)-catabolic enzymes (TCEs) produce metabolites that activate the aryl hydrocarbon receptor (AHR) and promote tumor progression and immunosuppression in glioblastoma. As therapies targeting TCEs or AHR become available, a...
2.
Rissling O, Kaiser L, Schulz S, Langer G, Schwingshackl L
Z Evid Fortbild Qual Gesundhwes
. 2021 Jul;
164:79-89.
PMID: 34253480
Objective: To provide Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) guidance for assessing inconsistency, imprecision, and other domains for the certainty of evidence about the relative importance of outcomes....
3.
Schulz S, Passon A, Perleth M, Kulig M, Paschke N, Matthias K
Dtsch Arztebl Int
. 2021 Feb;
117(50):868-869.
PMID: 33612156
No abstract available.
4.
Kaiser L, Hubscher M, Rissling O, Schulz S, Langer G, Meerpohl J, et al.
Z Evid Fortbild Qual Gesundhwes
. 2021 Jan;
160:78-88.
PMID: 33461905
Objectives: The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) working group defines patient values and preferences as the relative importance patients place on the main health outcomes. We provide...
5.
Unger M, Schumacher L, Enzlein T, Weigt D, Zamek-Gliszczynski M, Schwab M, et al.
Anal Chem
. 2020 Sep;
92(17):11851-11859.
PMID: 32867487
OATP2B1, a member of the solute carrier (SLC) transporter family, is an important mechanism of substrate drug uptake in the intestine and liver and therefore a determinant of clinical pharmacokinetics...
6.
Sammour D, Marsching C, Geisel A, Erich K, Schulz S, Ramallo Guevara C, et al.
Sci Rep
. 2019 Jul;
9(1):10698.
PMID: 31337874
Mass spectrometry imaging (MSI) is an enabling technology for label-free drug disposition studies at high spatial resolution in life science- and pharmaceutical research. We present the first extensive clinical matrix-assisted...
7.
Schulz S, Becker M, Groseclose M, Schadt S, Hopf C
Curr Opin Biotechnol
. 2018 Aug;
55:51-59.
PMID: 30153614
Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) has emerged as a key technology for label-free bioanalysis of the spatial distribution of biomolecules, pharmaceuticals and other xenobiotics in tissue sections....
8.
Rabe J, Sammour D, Schulz S, Munteanu B, Ott M, Ochs K, et al.
Sci Rep
. 2018 Apr;
8(1):6361.
PMID: 29670167
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
9.
Schulz S, Maitz M, Hansel S, Renner L, Werner C
Biomater Sci
. 2018 Mar;
6(5):1129-1139.
PMID: 29542739
Advanced blood contacting biomaterials are designed to combine antiseptic and anticoagulant functionalities. Here, we present a new in vitro methodology for the analysis of bacterial adhesion and growth after the...
10.
Rabe J, Sammour D, Schulz S, Munteanu B, Ott M, Ochs K, et al.
Sci Rep
. 2018 Jan;
8(1):313.
PMID: 29321555
Multimodal imaging combines complementary platforms for spatially resolved tissue analysis that are poised for application in life science and personalized medicine. Unlike established clinical in vivo multimodality imaging, automated workflows...